SIREN : 348571282
BIOPACK is a French company founded 37 years ago, specialized in the sector Activités de conditionnement. Based in VAL-DE-REUIL (27100), this company of category ETI shows in 2024 a revenue of 61.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 61 742 435 € | 66 194 113 € | 50 904 733 € |
| Net income | 10 001 291 € | 10 911 829 € | 7 978 317 € |
| EBITDA | 18 005 788 € | 18 498 479 € | 13 524 729 € |
| Net margin | 16.2% | 16.5% | 15.7% |
In 2024, BIOPACK achieves revenue of 61.7 M€. Over the period 2022-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +10.1%. Slight decline of -7% vs 2023. After deducting consumption (23.2 M€), gross margin stands at 38.6 M€, i.e. a rate of 62%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 18.0 M€, representing 29.2% of revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 10.0 M€, i.e. 16.2% of revenue. This profit can be retained or distributed to shareholders.
61 742 435 €
38 581 139 €
18 005 788 €
13 936 334 €
10 001 291 €
29.2%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 18.8% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
0.0%
56.264%
18.776%
0.0
28.6%
In 2024, the debt ratio of BIOPACK (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of BIOPACK (56.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of BIOPACK (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 204.10. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 2.9x. Financial charges are adequately covered by operations.
204.104
2.86
In 2024, the liquidity ratio of BIOPACK (204.10) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of BIOPACK (2.9x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 48 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 54 days. Favorable situation: supplier credit is longer than customer credit by 6 days. Inventory turnover is 20 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 151 days of revenue, i.e. 25.9 M€ to permanently finance.
25 865 758 €
48 j
54 j
20 j
151 j
Based on 158 transactions of similar company sales (all years), the value of BIOPACK is estimated at 43 172 593 € (range 14 918 970€ - 99 471 044€). With an EBITDA of 18 005 788€, the sector multiple of 3.3x is applied. The price/revenue ratio is 0.36x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 158 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIOPACK with other companies in the same sector:
Voir toutes les statistiques du secteur Activités de conditionnement
The revenue of BIOPACK in 2024 is 61.7 M€.
Yes, BIOPACK generated a net profit of 10.0 M€ in 2024.
The headquarters of BIOPACK is located in VAL-DE-REUIL (27100), in the department Eure.
The tax return of BIOPACK is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIOPACK operates in the sector Activités de conditionnement (NAF code 82.92Z). See the 'Sector positioning' section above to compare the company with its competitors.